Pharmacokinetic factors affecting airway selectivity of inhaled steroids – role of prodrug conversion and absorption Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Reversible intracellular esterification increases budesonide airway selectivity Source: Eur Respir J 2001; 18: Suppl. 33, 158s Year: 2001
Carrier-mediated disposal mechanisms for long-acting β2 -agonists in the airway: the emerging role of corticosteroid sensitivity Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma Source: Eur Respir J 2006; 28: 1042-1050 Year: 2006
Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001
Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology Source: Eur Respir J 2001; 17: 157-158 Year: 2001
Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019 Year: 2019
Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
The in vitro effect of corticosteroids on components of airway remodeling Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Source: Eur Respir J 2002; 19: 872-878 Year: 2002
Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling Source: Eur Respir J 2009; 34: 958-966 Year: 2009
The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
The effect of inhaled corticosteroids on airway Na/K ATPase content in patients with asthma Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Corticosteroid lipophilicity is a more important determinant of corticosteroid uptake into human hepatocytes than serum protein binding Source: Eur Respir J 2007; 30: Suppl. 51, 351s Year: 2007